CONCLUSION: GnRHa effectively suppressed sex hormone levels in adolescents with GD, although gonadotropin suppression was not complete, particularly in the Tanner 4/5 group, where gonadotropin levels remained elevated. Side effects were frequently reported, particularly in the Tanner 4/5 group, while the impact on pubertal development was limited. Therefore, the benefits and drawbacks of GnRHa treatment should be carefully considered, particularly in adolescents at Tanner stages 4 and 5.
